Studies of food drug interactions

Pakistan Journal of Pharmaceutical Sciences

Volumn 23, Issue 3, 2010, Pages 313-320

  Aman, Syed Faisal ^a   Hassan, Fouzia ^a   Naqvi, Baqar S ^a   Hasan, Syed Muhammmad Farid ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Asian population; Food drug interactions; Prescriptions

Indexed keywords

ALUMINUM HYDROXIDE; AMOXICILLIN; CEFACLOR; CEFALEXIN; CEFROXADINE; CEFUROXIME AXETIL; CIMETIDINE; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANATE POTASSIUM; DOXYCYCLINE; ENOXACIN; HYDROCHLOROTHIAZIDE; IRBESARTAN; LABETALOL; LEVOFLOXACIN; MAGNESIUM; METOPROLOL; NIFEDIPINE; NITROFURANTOIN; OFLOXACIN; PROPANTHELINE BROMIDE; PROPRANOLOL; SIMVASTATIN; SPARFLOXACIN; SUCRALFATE; TETRACYCLINE DERIVATIVE; TOLBUTAMIDE; UNINDEXED DRUG; WARFARIN;

AREA UNDER THE CURVE; ARTICLE; ASIAN; DAIRY PRODUCT; DRUG BIOAVAILABILITY; DRUG DISPOSITION; DRUG METABOLISM; FOOD; FOOD DRUG INTERACTION; HUMAN; MEAL; MILK; PRESCRIPTION; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHILD; CHILD, PRESCHOOL; FEMALE; FOOD-DRUG INTERACTIONS; HUMANS; MALE; MIDDLE AGED;

EID: 77953877817     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Alemdaroglu NC, Dietz U, Wolffram S, Spahn-Langguth H and Langguth P (2008). Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability. Biopharm. Drug Dispos., 29(6): 335-348.
2. Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H and Sallam AA (2008). Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Clin. Ther., 30(10): 1831-1843.
3. Beermann B and Groschinsky-Grind M (1978). Gastrointestinal absorption of hydrochlorothiazide enhanced by concomitant intake of food. Eur. J. Clin. Pharmacol., 13: 125.
4. Bland SE (1998). Drug-food interactions. J. Pharm. Soc. Wis., Nov/Dec., 28-35.
5. D' Arcy PF (1985). Nitrofurantoin. Drug Intell. Clin. Pharm., 19(7-8): 540-547.
6. Fassbender M, Lode H, Schaberg T, Borner K and Koeppe P (1993). Pharmacokinetics of new oral cephalosporins, including a new carbacephem. Clin. Infect. Dis., 16(5): 646-653. (Pubitemid 23136563)
7. Foulds G, Luke DR, Teng R, Willavize SA, Friedman H and Curatolo WJ (1996). The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension. J. Antimicrob. Chemother., 37(Suppl. C): 37-44. (Pubitemid 26283378)
8. th Edn., Lea and Febiger, Philadelphia, p.33.
9. Hamaguchi T, Shinkuma D, Yamanaka Y and Mizuno N (1987). Effects of food on absorption of mefenamic acid from two commercial capsules differing in bioavailability under the fasting state. J. Pharmacobiodyn., 10(1): 21-25.
10. Hasan SMF, Ahmed T, Talib N and Hasan F (2005). Pharmacokinetics of diclofenac sodium in normal man. Pak. J. Pharm. Sci., 18(1):18-24.
11. Heading RC, Nimo J, Prescott LF and Tothill P (1973). The dependence of paracetamol absorption on the rate of rastric emptying. Br. J. Pharmacol., 47: 415-421.
12. Johnson RD, Dorr MB, Hunt TL, Jensen BK and Talbot GH (1999). Effects of food on the pharmacokinetics of sparfloxacin. Clin. Ther., 21(6): 982-991.
13. Juárez-Olguín H, Flores J, Pérez G, Hernández G, Flores C, Guillé A, Camacho A, Toledo A, Carrasco M and Lares I (2002). Bioavailability of ranitidine in healthy Mexican volunteers: Effect of food. Proc. West Pharmacol. Soc., 45: 156-158. (Pubitemid 35253077)
14. Kappas A, Alvares AP, Anderson KE, Pantuck EJ, Pantuck CB, Chang R and Conney AH (1978). Effect of charcoal - broiled beef on antipyrine and theophylline metabolism. Clin. Pharmacol. Ther., 23: 445-450.
15. Karim S, Ahmed T, Monif T, Saha N and Sharma PL (2003). The effect of four different types of food on the bioavailability of cefaclor. Eur. J. Drug Metab. Pharmacokinet., 28(3): 185-190.
16. Kawakami J, Matsuse T, Kotaki H, Seino T, Fukuchi Y, Orimo H, Sawada Y and Iga T (1994). The effect of food on the interaction of ofloxacin with sucralfate in healthy volunteers. Eur. J. Clin. Pharmacol., 47(1): 67-69.
17. Koch-Weser J (1974). Bioavailability of drugs. N. Engl. J. Med., 291: 233-237, 503-506.
18. Kshirsagar NA and Ankalesaria PS (1987). Effect of food on doxycycline absorption. J. Postgrad. Med., 33:117-119.
19. Lecaillon JB, Hirtz JL, Schoeller JP, Humbert G and Vischer W (1980). Pharmacokinetic comparison of cefroxadin (CGP 9000) and cephalexin by simultaneous administration to humans. Antimicrob. Agents Chemother., 18(5): 656-660.
20. Lee LJ, Hafkin B, Lee ID, Hoh J and Dix R (1997). Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects. Antimicrob. Agents Chemother., 41(10): 2196-2200. (Pubitemid 27422212)
21. Lehto P and Kivistö KT (1995). Effects of milk and food on the absorption of enoxacin. Br. J. Clin. Pharmacol., 39(2): 194-196.
22. Mäntylä R, Männistö PT, Vuorela A, Sundberg S and Ottoila P (1984). Impairment of captopril bioavailability by concomitant food and antacid intake. Int. J. Clin. Pharmacol. Ther. Toxicol., 22(11): 626-629. (Pubitemid 15201402)
23. Marathe PH, Arnold ME, Meeker J, Greene DS and Barbhaiya RH (2000). Pharmacokinetics and bioavailability of a metformin/glyburide tablet administered alone and with food. J. Clin. Pharmacol., 40(12 Pt 2): 1494-1502.
24. Marino MR and Vachharajani NN (2001). Drug interactions with irbesartan. Clin. Pharmacokinet., 40(8): 605-614.
25. Marzo A, Dal Bo L, Wool C and Cerutti R (1998). Bioavailability, food effect and tolerability of S-naproxen betainate sodium salt monohydrate in steady state. Arzneimittelforschung., 48(9): 935-940.
26. Mattok GL and McGilveray IJ (1973). The effect of food intake and sleep on the absorption of acetaminophen. Revue Canadienne de Biologie, 32: 77-84.
27. Melander A, Stenberg P, Liedolm H, Schersten B and Wahlin-Boll E (1979). Food induced reduction in bioavailability of atenolol. Eur. J. Clin. Pharmacol., 16: 327-330.
28. Melander A (1978). Influence of food on the bioavailability of drugs. Clin. Pharmacokinet., 3(5): 337-351.
29. Melander A, Danielson K, Hanson A, Rudell B, Schersien B, Thulin T and Wahlin E (1977a). Enhancement of hydralazine bioavailability by food. Clin. Pharmacol. Ther., 22: 104-107.
30. Melander A, Danielson K, Schersten B, Thulin T and Wahlin E (1977b). Enhancement by food of canrenone bioavailability from spironolactone. Clin. Pharmacol. Ther., 22: 100-103. (Pubitemid 8155118)
31. Nomeir AA, Mojaverian P, Kosoglou T, Affrime MB, Nezamis J, Rodwanski E, Lin CC and Cayen MN (1996). Influence of food on the oral bioavailability of loratadine and pseudoephedrine from extended-release tablets in healthy volunteers. J. Clin. Pharmacol., 36(10): 923-930.
32. Panchagnula R, Rungta S, Sancheti P, Agrawal S and Kaul CL (2003). In vitro evaluation of food effect on the bioavailability of rifampicin from antituberculosis fixed dose combination formulations. Farmaco, 58(11): 1099-1103.
33. Pargal A, Kelkar MG and Nayak PJ (1996). The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations. Biopharm. Drug Dispos., 17(6): 511-519.
34. Peloquin CA, Namdar R, Dodge AA and Nix DE (1999a). Pharmacokinetics of isoniazid under fasting conditions with food, and with antacids. Int. J. Tuberc. Lung Dis., 3(8): 703-710. (Pubitemid 29378471)
35. Peloquin CA, Bulpitt AE, Jaresko GS, Jelliffe RW, Childs JM and Nix DE (1999b). Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids. Antimicrob. Agents Chemother., 43(3): 568-572.
36. Peloquin CA, Bulpitt AE, Jaresko GS, Jelliffe RW, James GT and Nix DE (1998). Pharmacokinetics of pyrazinamide under fasting conditions, with food, and with antacids. Pharmacotherapy, 18(6): 1205-1211.
37. Prescott LF (1974). Gastrointestinal absorption of drugs. Med. Clin. North Am., 58: 907-916.
38. Rosenblatt JE, Barrett JE, Brodie JL and Kirby WMM (1966). Comparison of in vitro activity and clinical pharmacology of doxycycline with other tetracyclines. Antimicrob. Ag. Chemother.,6:134-141.
39. Scheiner J and Altemeier WA (1962). Experimental study of factors inhibiting absorption and effective therapeutic levels of declomycin. Surg. Gynec. Obstet., 114: 9.
40. Shah A, Liu MC, Vaughan D and Heller AH (1999). Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension. J. Antimicrob. Chemother., 43(Suppl A): 49-54.
41. Sifton DW (2000) (ed.). Physicians Desk Reference. Medical Economics Company, Inc., Montvale, N.J., pp.1346-1349.
42. Sindhu S, Malhotra S and Garg SK (2004). Influence of high fat diet (butter) on pharmacokinetics of phenytoin and carbamazepine. Methods Find Exp. Clin. Pharmacol., 26(8): 634-638.
43. Song JC and White CM (2002). Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: An update. Clin. Pharmacokinet., 41(3): 207-224.
44. Sostek MB, Chen Y and Andersson T (2007). Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole. Br. J. Clin. Pharmacol., 64(3): 386-390. (Pubitemid 47283859)
45. Spiers ASD and Malone HF (1967). Effect of food on aspirin absorption. Lancet, i: 440.
46. Staniforth DH, Clarke HL, Horton R, Jackson D and Lau D (1985). Augmentin bioavailability following cimetidine, aluminum hydroxide and milk. Int. J. Clin. Pharmacol. Ther. Toxicol., 23(3): 154-157.
47. nd Edn., Blackwell Scientific Publications, Oxford, pp.43, 150-151, 313.
48. Thomson AB, Sinclair P, Matisko A, Rosen E, Andersson T and Olofsson B (1997). Influence of food on the bioavailability of an enteric-coated tablet formulation of omeprazole 20 mg under repeated dose conditions. Can. J. Gastroenterol., 11(8):663-667. Comment in: Can. J. Gastroenterol., 11(8): 655-656.
49. Vasu S, Adithan C, Shashindran CH, Asad M, Koumaravelou K and Topno I (2000). Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil. Indian J. Med. Res., 112: 104-108.
50. Verbeeck RK, Richardson CJ and Blocka KL (1986). Clinical pharmacokinetics of piroxicam. J. Rheumatol., 13(4): 789-796.
51. Wagner JG (1977). Drug bioavailability studies. Hosp. Pract., 12: 119-127.
52. Welling PG (1984). Interactions affecting drug absorption. Clin. Pharmacokinet., 9(5): 404-434.
53. Welling PG (1977). How food and fluid affect drug absorption. Postgrad. Med., 62: 73-82.
54. Wood JH (1967). Effect of food on aspirin absorption. Lancet, ii: 212.
55. Zmeili S, Hasan M, Najib N, Sallam E, Deleq S and Shubair M (1996). Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: Effect of food on inflaban bioavailability. Int. J. Clin. Pharmacol. Ther., 34(12): 564-570.